Marian Rewers

Marian Rewers

Auto-generated profile, based on publicly available information

Marian Rewers

Barbara Davis Center for Childhood Diabetes, University of Colorado

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Science
Verified
Journal Article
Closed access
PDF file
MMMichael Mina
Michael Mina
TKTomasz Kula
Tomasz Kula
YLYumei Leng
Yumei Leng
MLMamie Li
Mamie Li
Rory de VriesRory de Vries
Rory de Vries
SEStephen J. Elledge
Stephen J. Elledge
The toll of measles on the immune system: Many of the deaths attributable to measles virus are caused by secondary infections because the virus infects and functionally impairs immune cells. Whether measles infection causes long-term damage to immune memory has been unclear. This question has become increasingly important given the resurgence in measles epidemics worldwide. Using a blood test called VirScan, Mina et al. comprehensively analyzed the antibody repertoire in children before and after natural infection with measles virus as well as in children before and after measles vaccination. They found that measles infection can greatly diminish previously acquired immune memory, potentially leaving individuals at risk for infection by other pathogens. These adverse effects on the immune system were not seen in vaccinated children. Science , this issue p. 599

24 June 2024 in Diabetes Care
Verified
Journal Article
Open access
PDF file
MPMoshe Phillip
Moshe Phillip
PAPeter Achenbach
Peter Achenbach
AAAnanta Addala
Ananta Addala
AAAnastasia Albanese-O’neill
Anastasia Albanese-O’neill
TBTadej Battelino
Tadej Battelino
LDLinda DiMeglio
Linda DiMeglio
Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programs are being increasingly emphasized. Once broadly implemented, screening initiatives will identify significant numbers of islet autoantibody–positive (IAb+) children and adults who are at risk for (confirmed single IAb+) or living with (multiple IAb+) early-stage (stage 1 and stage 2) type 1 diabetes. These individuals will need monitoring for disease progression; much of this care will happen in nonspecialized settings. To inform this monitoring, JDRF, in conjunction with international experts and societies, developed consensus guidance. Broad advice from this guidance includes the following: 1) partnerships should be fostered between endocrinologists and primary care providers to care for people who are IAb+; 2) when people who are IAb+ are initially identified, there is a need for confirmation using a second sample; 3) single IAb+ individuals are at lower risk of progression than multiple IAb+ individuals; 4) individuals with early-stage type 1 diabetes should have periodic medical monitoring, including regular assessments of glucose levels, regular education about symptoms of diabetes and DKA, and psychosocial support; 5) interested people with stage 2 type 1 diabetes should be offered trial participation or approved therapies; and 6) all health professionals involved in monitoring and care of individuals with type 1 diabetes have a responsibility to provide education. The guidance also emphasizes significant unmet needs for further research on early-stage type 1 diabetes to increase the rigor of future recommendations and inform clinical care.

20 January 2014 in Pediatric Diabetes
Verified
Journal Article
Open access
PDF file
MLMolly M Lamb
Molly M Lamb
MMMelissa Miller
Melissa Miller
JSJennifer A. Seifert
Jennifer A. Seifert
BFBrittni Frederiksen
Brittni Frederiksen
MKMiranda Kroehl
Miranda Kroehl
JNJill M. Norris
Jill M. Norris
Background Cow's milk intake has been inconsistently associated with islet autoimmunity (IA) and type 1 diabetes (T1D) development. Genetic and environmental factors may modify the effect of cow's milk on IA and T1D risk. Methods The Diabetes Autoimmunity Study in the Young (DAISY) follows children at increased T1D risk of IA (presence of autoantibodies to insulin, GAD65, or IA‐2 twice in succession) and T1D development. We examined 1835 DAISY children with data on cow's milk intake: 143 developed IA, 40 subsequently developed T1D. Cow's milk protein and lactose intake were calculated from prospectively collected parent‐ and self‐reported food frequency questionnaires (FFQ). High risk HLA‐DR genotype: HLA‐DR3/4,DQB1*0302; low/moderate risk: all other genotypes. We examined interactions between cow's milk intake, age at cow's milk introduction, and HLA‐DR genotype in IA and T1D development. Interaction models contained the base terms (e.g., cow's milk protein and HLA‐DR genotype) and an interaction term (e.g., cow's milk protein*HLA‐DR genotype). Results In survival models adjusted for total calories, FFQ type, T1D family history, and ethnicity, greater cow's milk protein intake was associated with increased IA risk in children with low/moderate risk HLA‐DR genotypes [hazard ratio (HR): 1.41, 95% confidence interval (CI): 1.08–1.84], but not in children with high risk HLA‐DR genotypes. Cow's milk protein intake was associated with progression to T1D (HR: 1.59, CI: 1.13–2.25) in children with IA. Conclusions Greater cow's milk intake may increase risk of IA and progression to T1D. Early in the T1D disease process, cow's milk intake may be more influential in children with low/moderate genetic T1D risk.

24 June 2024 in Diabetologia
Verified
Journal Article
Open access
PDF file
MPMoshe Phillip
Moshe Phillip
PAPeter Achenbach
Peter Achenbach
AAAnanta Addala
Ananta Addala
AAAnastasia Albanese-O’nEill
Anastasia Albanese-O’nEill
TBTadej Battelino
Tadej Battelino
LDLinda DiMeglio
Linda DiMeglio
Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programmes are being increasingly emphasised. Once broadly implemented, screening initiatives will identify significant numbers of islet autoantibody-positive (IAb+) children and adults who are at risk of (confirmed single IAb+) or living with (multiple IAb+) early-stage (stage 1 and stage 2) type 1 diabetes. These individuals will need monitoring for disease progression; much of this care will happen in non-specialised settings. To inform this monitoring, JDRF in conjunction with international experts and societies developed consensus guidance. Broad advice from this guidance includes the following: (1) partnerships should be fostered between endocrinologists and primary-care providers to care for people who are IAb+; (2) when people who are IAb+ are initially identified there is a need for confirmation using a second sample; (3) single IAb+ individuals are at lower risk of progression than multiple IAb+ individuals; (4) individuals with early-stage type 1 diabetes should have periodic medical monitoring, including regular assessments of glucose levels, regular education about symptoms of diabetes and DKA, and psychosocial support; (5) interested people with stage 2 type 1 diabetes should be offered trial participation or approved therapies; and (6) all health professionals involved in monitoring and care of individuals with type 1 diabetes have a responsibility to provide education. The guidance also emphasises significant unmet needs for further research on early-stage type 1 diabetes to increase the rigour of future recommendations and inform clinical care. Graphical Abstract

31 March 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LXLouis-Pascal Xhonneux
Louis-Pascal Xhonneux
OKOliver Knight
Oliver Knight
ÅLÅke Lernmark
Åke Lernmark
EBEzio Bonifacio
Ezio Bonifacio
WHWilliam A. Hagopian
William A. Hagopian
EMEoin F. McKinney
Eoin F. McKinney
Transcriptomic analysis identifies progression signatures facilitating prediction of individual T1D risk from 18 months of age in independent cohorts.

24 January 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
MTMichael Tisza
Michael Tisza
RLRichard E. Lloyd
Richard E. Lloyd
KHKristi Hoffman
Kristi Hoffman
DSDaniel Smith
Daniel Smith
MRMarian Rewers
Marian Rewers
JPJoseph F. Petrosino
Joseph F. Petrosino
Microbial colonization of the human gut occurs soon after birth, proceeds through well-studied phases and is affected by lifestyle and other factors. Less is known about phage community dynamics during infant gut colonization due to small study sizes, an inability to leverage large databases and a lack of appropriate bioinformatics tools. Here we reanalysed whole microbial community shotgun sequencing data of 12,262 longitudinal samples from 887 children from four countries across four years of life as part of the The Environmental Determinants of Diabetes in the Young (TEDDY) study. We developed an extensive metagenome-assembled genome catalogue using the Marker-MAGu pipeline, which comprised 49,111 phage taxa from existing human microbiome datasets. This was used to identify phage marker genes and their integration into the MetaPhlAn 4 bacterial marker gene database enabled simultaneous assessment of phage and bacterial dynamics. We found that individual children are colonized by hundreds of different phages, which are more transitory than bacteria, accumulating a more diverse phage community over time. Type 1 diabetes correlated with a decreased rate of change in bacterial and viral communities in children aged one and two. The addition of phage data improved the ability of machine learning models to discriminate samples by country. Finally, although phage populations were specific to individuals, we observed trends of phage ecological succession that correlated well with putative host bacteria. This resource improves our understanding of phage–bacteria interactions in the developing early life microbiome.